Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.
Geller F, Wu X, Lammi V, Abner E, Valliere JT, Nastou K, Rasmussen M, Andersson NW, Quinn L; DBDS Genomic Consortium; Aagaard B, Banasik K, Bliddal S, Boding L, Brunak S, Brøns N, Bybjerg-Grauholm J, Christoffersen LAN, Didriksen M, Dinh KM, Erikstrup C, Feldt-Rasmussen U, Grønbæk K, Kaspersen KA, Mikkelsen C, Nielsen CH, Nielsen HS, Nielsen SD, Nissen J, Sequeros CB, Tommerup N, Ullum H; Estonian Biobank Research Team; FinnGen, Spiliopoulos L, Bager P, Hviid A, Sørensen E, Pedersen OB, Lane JM, Lassaunière R, Ollila HM, Ostrowski SR, Feenstra B.
Geller F, et al. Among authors: gronbaek k.
medRxiv [Preprint]. 2024 Nov 22:2024.11.21.24317689. doi: 10.1101/2024.11.21.24317689.
medRxiv. 2024.
PMID: 39606378
Free PMC article.
Preprint.
No abstract available.